Continue reading this on our app for a better experience

Open in App
Home Capital Broker's Calls

Singapore Medical Group's outlook seen as rosy with latest acquisition

Michelle Zhu
Michelle Zhu • 2 min read
Singapore Medical Group's outlook seen as rosy with latest acquisition
SINGAPORE (Oct 20): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group with an unchanged target price of 78 cents which is pegged at 27 times FY18 earnings.
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.